BioCardia, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for BioCardia, Inc. (BCDA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are BCDA insiders buying or selling?
In the last 12 months, BioCardia, Inc. insiders reported 22 open-market purchases ($169.2K) and 0 sales ($0) — net buying of $169.2K. Since March 2018, Trabud has recorded 138 Form 4 filings for BCDA: 135 buys ($14.7M) and 3 sells ($79.3K).
Source: SEC EDGAR Form 4
What stands out
- The largest open-market purchase in the last 12 months was $103.6K by STERTZER SIMON H (Director) on Jun 24, 2026. SEC ↗
- The most recent open-market purchase was reported on Sep 30, 2026 (18 days ago).
Key Statistics (March 2018 – Sep 30, 2026)
Total Form 4 filings
138
SEC EDGAR
Insider filers
10
Insider buys (135)
$14.7M
Insider sells (3)
$79.3K
Insider sentiment
Net buyingNet insider flow of $14.6M in net buying since March 2018, and $169.2K in net buying over the last 12 months. 6 insider buys in the last 90 days.
Recent BCDA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Peter Altman | President and CEO | Purchase | 1.0K | $1.03 | $1.0K | SEC ↗ |
| Sep 24, 2026 | Peter Altman | President and CEO | Purchase | 1.9K | $1.05 | $2.0K | SEC ↗ |
| Sep 5, 2026 | Peter Altman | President and CEO | Purchase | 800 | $1.09 | $872 | SEC ↗ |
| Aug 18, 2026 | Peter Altman | President and CEO | Purchase | 5.4K | $0.93 | $5.0K | SEC ↗ |
| Aug 13, 2026 | Peter Altman | President and CEO | Purchase | 1.9K | $0.92 | $1.7K | SEC ↗ |
| Jul 30, 2026 | Peter Altman | President and CEO | Purchase | 5.0K | $0.78 | $3.9K | SEC ↗ |
| Jul 20, 2026 | Peter Altman | President and CEO | Purchase | 500 | $0.83 | $415 | SEC ↗ |
| Jul 15, 2026 | Peter Altman | President and CEO | Purchase | 4.3K | $0.87 | $3.8K | SEC ↗ |
| Jul 10, 2026 | Peter Altman | President and CEO | Purchase | 7.5K | $0.96 | $7.2K | SEC ↗ |
| Jul 8, 2026 | Peter Altman | President and CEO | Purchase | 5.4K | $0.96 | $5.2K | SEC ↗ |
| Jun 24, 2026 | STERTZER SIMON H | Director | Purchase | 109.2K | $0.95 | $103.6K | SEC ↗ |
| Jun 22, 2026 | Peter Altman | President and CEO | Purchase | 2.3K | $0.89 | $2.0K | SEC ↗ |
| Jun 9, 2026 | Peter Altman | President and CEO | Purchase | 5.0K | $0.85 | $4.3K | SEC ↗ |
| May 21, 2026 | Peter Altman | President and CEO | Purchase | 1.7K | $0.92 | $1.6K | SEC ↗ |
| May 19, 2026 | Peter Altman | President and CEO | Purchase | 5.7K | $0.92 | $5.2K | SEC ↗ |
| May 15, 2026 | Peter Altman | President and CEO | Purchase | 5.1K | $1.02 | $5.2K | SEC ↗ |
| Apr 29, 2026 | Peter Altman | President and CEO | Purchase | 5.0K | $1.11 | $5.5K | SEC ↗ |
| Apr 22, 2026 | Peter Altman | President and CEO | Purchase | 1.0K | $1.23 | $1.2K | SEC ↗ |
| Mar 27, 2026 | Peter Altman | President and CEO | Purchase | 900 | $1.23 | $1.1K | SEC ↗ |
| Feb 4, 2026 | Peter Altman | President and CEO | Purchase | 5.0K | $1.13 | $5.7K | SEC ↗ |
| Jan 21, 2026 | Peter Altman | President and CEO | Purchase | 900 | $1.33 | $1.2K | SEC ↗ |
| Dec 17, 2025 | Peter Altman | President and CEO | Purchase | 1.1K | $1.31 | $1.4K | SEC ↗ |
| Sep 23, 2025 | STERTZER SIMON H | Director | Purchase | 398.4K | $1.25 | $498.0K | SEC ↗ |
| Sep 23, 2025 | Andrew Scott Blank | Director | Purchase | 288.0K | $1.25 | $360.0K | SEC ↗ |
| Sep 23, 2025 | Peter Altman | President and CEO | Purchase | 48.0K | $1.25 | $60.0K | SEC ↗ |
Showing the 25 most recent of 138 Form 4 filings for BioCardia, Inc..
Most active BCDA insiders
- Peter Altman96 filings
- STERTZER SIMON H22 filings
- David Mcclung8 filings
- Andrew Scott Blank4 filings
- Phillip Frost MD ET AL3 filings
Ask anything about BCDA insider activity
Use Trabud's AI agent to query BioCardia, Inc.'s Form 4 history in plain English — "Show me BCDA CEO purchases this year" or compare it against any other ticker.
Open the AI agentBCDA insider trading FAQ
Are BioCardia, Inc. insiders buying or selling?
In the last 12 months, BioCardia, Inc. insiders reported 22 open-market purchases ($169.2K) and 0 sales ($0) — net buying of $169.2K. Since March 2018, Trabud has recorded 138 Form 4 filings for BCDA: 135 buys ($14.7M) and 3 sells ($79.3K). Over the full record that is net buying of $14.6M.
How many insiders trade BCDA stock?
10 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for BioCardia, Inc.. The most recent filing was accepted on Sep 30, 2026.
Where does Trabud get BCDA insider trading data?
All BCDA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.